Although the specific gene responsible for cystic fibrosis (CF), CFTR, has been known for almost 20 years, the failure of CFTR–/– mice to develop human-like CF symptoms has limited the use of this animal model. In order to create an animal model that more closely represents human CF, researchers created transgenic CFTR–/– domestic pigs using tools and methods of mouse genetic manipulation. As with newborn humans, newborn pigs lacking CFTR initially showed no signs of disease. However, within a few days after birth they developed severe symptoms similar to the clinical manifestations of human CF. These symptoms included intestinal blockage (meconium ileus), exocrine pancreatic insufficiency and damage, and liver disease (focal biliary cirrhosis). Respiratory symptoms and lung disease are the primary causes of human CF mortality and morbidity, but symptom onset does not take place immediately; patients begin developing symptoms anywhere between 3 months to several years after birth. Similar to human neonates, the CFTR–/– piglets do not have obvious lung abnormalities at birth, but analyzing CFTR–/– pigs later in life might reveal progressive lung changes over time.
Cystic fibrosis: transgenic pigs mimic human symptoms Open Access
- Split-screen
- Views Icon Views Open Menu
- Open the PDF for in another window
-
Article Versions Icon
Versions
- Version of Record 21 November 2008
- Share Icon Share
-
Tools Icon
Tools
Open Menu
- Search Site
Cystic fibrosis: transgenic pigs mimic human symptoms. Dis Model Mech 21 November 2008; 1 (4-5): 185. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Propose a new Workshop for 2027

We are currently seeking proposals for Workshops to be held in 2027. As one of the scientific organisers of a The Company of Biologists Workshop, your involvement will be focused on interdisciplinary, cutting-edge science and promoting new partnerships and collaborations. We focus on the logistics. Are you thinking about proposing a topic for one of our Workshops? Apply by Friday 30 May 2025.
Other journals from
The Company of Biologists